Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Loci other than 21q22.12 (RUNX1) and 16q21–23.2 cause familial AML

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999; 23: 166–175.

    Article  CAS  Google Scholar 

  2. Ganly P, Walker LC, Morris CM . Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia. Leuk Lymphoma 2004; 45: 1–10.

    Article  CAS  Google Scholar 

  3. Horwitz M, Benson KF, Li FQ, Wolff J, Leppert MF, Hobson L et al. Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21–23.2. Am J Hum Genet 1997; 61: 873–881.

    Article  CAS  Google Scholar 

  4. De Lord C, Powles R, Mehta J, Wilson K, Treleaven J, Meller S et al. Familial acute myeloid leukaemia: four male members of a single family over three consecutive generations exhibiting anticipation. Brit J Haemat 1998; 100: 557–560.

    Article  CAS  Google Scholar 

  5. Arepally G, Rebbeck TR, Song W, Gilliland G, Maris JM, Poncz M . Evidence for genetic homogeneity in a familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML). Blood 1998; 92: 2600–2602.

    CAS  PubMed  Google Scholar 

  6. Escher R, Hagos F, Michaud J, Sveen L, Horwitz M, Olopade OI et al. No evidence for core-binding factor CBFbeta as a leukemia predisposing factor in chromosome 16q22-linked familial AML. Leukemia 2004; 18: 881.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to the family for their participation in the study and to Ray Powles. The work was supported by grants from the Leukaemia Research Fund and Cancer Research UK.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R S Houlston.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sellick, G., Pritchard-Jones, K., Shepherd, V. et al. Loci other than 21q22.12 (RUNX1) and 16q21–23.2 cause familial AML. Leukemia 19, 465–466 (2005). https://doi.org/10.1038/sj.leu.2403648

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403648

This article is cited by

Search

Quick links